ProShares Ultra Nasdaq Biotechnology Stock Forecast, Price & News

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Frequently Asked Questions

How has ProShares Ultra Nasdaq Biotechnology's stock been impacted by Coronavirus?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $47.23 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIB stock has increased by 79.4% and is now trading at $84.72.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V).

What is ProShares Ultra Nasdaq Biotechnology's stock symbol?

ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIB."

Who are ProShares Ultra Nasdaq Biotechnology's major shareholders?

ProShares Ultra Nasdaq Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Howard Capital Management Inc. (8.23%), Geneos Wealth Management Inc. (7.96%), OLD Mission Capital LLC (0.98%), Toth Financial Advisory Corp (0.87%), Orion Portfolio Solutions LLC (0.54%) and Citadel Advisors LLC (0.00%).

Which major investors are selling ProShares Ultra Nasdaq Biotechnology stock?

BIB stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Vontobel Holding Ltd., United Maritime Capital LLC, and Morgan Stanley.

Which major investors are buying ProShares Ultra Nasdaq Biotechnology stock?

BIB stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Geneos Wealth Management Inc., OLD Mission Capital LLC, Orion Portfolio Solutions LLC, Toth Financial Advisory Corp, Wolverine Trading LLC, Traynor Capital Management Inc., and Destiny Wealth Partners LLC.

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

One share of BIB stock can currently be purchased for approximately $84.72.

How much money does ProShares Ultra Nasdaq Biotechnology make?

ProShares Ultra Nasdaq Biotechnology has a market capitalization of $216.04 million.

What is ProShares Ultra Nasdaq Biotechnology's official website?

The official website for ProShares Ultra Nasdaq Biotechnology is www.proshares.com.

Where are ProShares Ultra Nasdaq Biotechnology's headquarters?

ProShares Ultra Nasdaq Biotechnology is headquartered at SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States.

How can I contact ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The exchange traded fund can be reached via phone at +1-240-4976400.